NOVAREX Co.,Ltd. (KOSDAQ:194700)

Market Cap	255.44B
Revenue (ttm)	385.76B
Net Income (ttm)	36.10B
Shares Out	17.70M
EPS (ttm)	2,039.00
PE Ratio	7.08
Forward PE	n/a
Dividend	200.00 (1.39%)
Ex-Dividend Date	Dec 29, 2025

Volume	100,803
Average Volume	121,032
Open	14,580
Previous Close	14,490
Day's Range	14,130 - 14,580
52-Week Range	6,650 - 22,100
Beta	0.22
RSI	35.60
Earnings Date	Nov 14, 2025

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 430
• Stock Exchange: KOSDAQ
• Ticker Symbol: 194700

Financial Performance

In 2024, NOVAREX's revenue was 297.73 billion, a decrease of -1.47% compared to the previous year's 302.17 billion. Earnings were 23.02 billion, an increase of 4.45%.